Xolair 150 MG/ML syringeml

Ended Awarded

Contract number
SPE2DB24FY22L
Awardee
Awarding agency
Obligated
$9,284

Award facts

Contract value 100% obligated
$9,284.40 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Xolair 150 mg/mL syringes. The contract, valued at $9,284.40, has an ultimate completion date of April 23, 2024. This delivery order falls under DMS Pharmaceutical Group's existing indefinite delivery contract, SPE2DB22D9362, with the DLA worth up to $4,999,999 through the end of 2025. This larger contract enables the DLA to issue firm fixed-price orders for a broad range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. The contract has no set-aside designation.

Quick answers

Who was awarded contract SPE2DB24FY22L?

SPE2DB24FY22L was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 2, 2024.

How much is contract SPE2DB24FY22L worth?

The government has obligated $9,284 on SPE2DB24FY22L.

Is contract SPE2DB24FY22L an order under another contract?

Yes. SPE2DB24FY22L is a delivery order under SPE2DB22D9362, an indefinite delivery contract.

Was contract SPE2DB24FY22L competed?

The extent of competition for SPE2DB24FY22L was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award